Gabriella Moretti - Concepedia

Author

Gabriella Moretti

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

G MORETTI, G Moretti, G. Moretti, Gabriella Moretti, Giaele Moretti, Mario Airoldi, Moretti, Gabriella, P. Minicozzi

172

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Istituto Superiore di Sanità Fondazione IRCCS Istituto Nazionale dei Tumori Azienda Sanitaria Unità Locale di Reggio Emilia Ospedale Santa Chiara

About

Gabriella Moretti is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, chromatography, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	542
2	Health Sciences	3	3	52
3	Engineering	2	2	25
4	Natural Sciences	1	1	13
5	Public Health	1	1	12

Gabriella Moretti

Publications

Citations

H-Index

Page 1

	Year	Citations
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study Pierfranco Conté, Antonio Frassoldati, Giancarlo Bisagni, Annals of Oncology	2018	152
Central Nervous System Metastases in HER-2–Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors Stefania Gori, S Rimondini, Verena De Angelis, The Oncologist	2007	145
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study Valentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, Annals of Oncology	2019	93
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, The Lancet Oncology Endocrine OncologyBreast OncologyMedicinePharmacologyEndocrine-sensitive Breast Cancer	2018	86
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni, The Lancet Oncology Breast OncologyOncologyPostmenopausal PatientsGynecologyAdjuvant Treatment	2021	82
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck Paolo Bossi, Rosalba Miceli, Laura D. Locati, Annals of Oncology MedicinePathologyFirst-line TreatmentHead And Neck CancerCancer Treatment	2017	80
A fatal postpartum Clostridium sordellii associated toxic shock syndrome. A. Bitti, Paola Mastrantonio, Patrizia Spigaglia, Journal of Clinical Pathology	1997	56
[Mycetes and bacteria]. R Bertamino, Gabriella Moretti, E Rampini PubMed BiologyUnicellular OrganismPathogenic MicrobiologyMicrobial DiseaseMicrobiology	1967	47
Determination of thyreostatic residues in cattle plasma by high-performance liquid chromatography with ultraviolet detection Gabriella Moretti, P. Betto, P. Cammarata, Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyAnimal ScienceBioanalysisThyreostatic ResiduesAnalytical Chemistry	1993	34
Analysis of steroid mixtures by column chromatography with continuous monitoring of the eluate by a flame ionisation detector G Cavina, Gabriella Moretti, Adriano Mollica, Journal of Chromatography A Continuous MonitoringGas ChromatographyMedicineSteroid MixturesAnalytical Chemistry	1971	27

Page 1